Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.
Schwid SR, Thorpe J, Sharief M, Sandberg-Wollheim M, Rammohan K, Wendt J, Panitch H, Goodin D, Li D, Chang P, Francis G; EVIDENCE (Evidence of Interferon Dose-Response: European North American Comparative Efficacy) Study Group; University of British Columbia MS/MRI Research Group.
Schwid SR, et al.
Arch Neurol. 2005 May;62(5):785-92. doi: 10.1001/archneur.62.5.785.
Arch Neurol. 2005.
PMID: 15883267
Clinical Trial.